These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22733221)

  • 21. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity.
    Smith EC; Ziogas A; Anton-Culver H
    JAMA Surg; 2013 Jun; 148(6):516-23. PubMed ID: 23615681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.
    Abraham HG; Xia Y; Mukherjee B; Merajver SD
    Breast Cancer Res Treat; 2021 Jan; 185(1):229-238. PubMed ID: 33033965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Socioeconomic and demographic disparities in breast cancer stage at presentation and survival: A Swiss population-based study.
    Feller A; Schmidlin K; Bordoni A; Bouchardy C; Bulliard JL; Camey B; Konzelmann I; Maspoli M; Wanner M; Clough-Gorr KM;
    Int J Cancer; 2017 Oct; 141(8):1529-1539. PubMed ID: 28657175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional and racial disparities in breast cancer-specific mortality.
    Grann V; Troxel AB; Zojwalla N; Hershman D; Glied SA; Jacobson JS
    Soc Sci Med; 2006 Jan; 62(2):337-47. PubMed ID: 16051406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Roche AM; Fedewa SA; Shi LL; Chen AY
    Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.
    Schairer C; Brown LM; Mai PL
    Breast Cancer Res Treat; 2011 Aug; 129(1):117-24. PubMed ID: 21390499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
    Aurit SJ; Devesa SS; Soliman AS; Schairer C
    Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory breast cancer outcomes by breast cancer subtype: a population-based study.
    Wu SG; Zhang WW; Wang J; Dong Y; Sun JY; Chen YX; He ZY
    Future Oncol; 2019 Feb; 15(5):507-516. PubMed ID: 30378451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
    Roche AM; Fedewa SA; Chen AY
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populations.
    Natori A; Hayashi N; Soejima K; Deshpande GA; Takahashi O; Cristofanilli M; Ueno NT; Yamauchi H
    Clin Breast Cancer; 2013 Dec; 13(6):460-4. PubMed ID: 24084032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States.
    Costa LJ; Brill IK; Brown EE
    Cancer; 2016 Oct; 122(20):3183-3190. PubMed ID: 27548407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory breast cancer, trimodal treatment, and mortality: Does where you live matter?
    Relation T; Li Y; Fisher JL; Tsung A; Oppong B; Eskander MF; Obeng-Gyasi S
    Surgery; 2022 Mar; 171(3):687-692. PubMed ID: 34857388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
    Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
    Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
    Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
    Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial/ethnic and socioeconomic survival disparities for children and adolescents with central nervous system tumours in the United States, 2000-2015.
    Mitchell HK; Morris M; Ellis L; Abrahão R; Bonaventure A
    Cancer Epidemiol; 2020 Feb; 64():101644. PubMed ID: 31783249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer.
    Van Berckelaer C; Van Geyt M; Linders S; Rypens C; Trinh XB; Tjalma WAA; Van Laere S; Colpaert C; Dirix L; van Dam PA
    Breast; 2020 Oct; 53():212-220. PubMed ID: 32890963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causes of death and relative survival of older women after a breast cancer diagnosis.
    Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
    J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Race, ethnicity and risk of second primary contralateral breast cancer in the United States.
    Watt GP; John EM; Bandera EV; Malone KE; Lynch CF; Palmer JR; Knight JA; Troester MA; Bernstein JL
    Int J Cancer; 2021 Jun; 148(11):2748-2758. PubMed ID: 33544892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.